SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following positive earnings and news of a significant AI lease deal, with the community buzzing about a potential short squeeze. A price target increase from Roth Capital is adding fuel to the fire, as investors discuss the company's prospects in AI infrastructure and data centers. Some community members are comparing it to other high-growth stocks and discussing strategies around calls and puts, while others are considering it for long-term investment.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ Corp is trending due to a strategic partnership focused on developing quantum-resistant chips for U.S. defense applications, igniting discussions about future government contracts. The community is actively evaluating the company's growth potential relative to other quantum computing stocks. Many investors are describing LAES as undervalued with potential for a significant upward trajectory.

Quoin Pharmaceuticals Ltd. engages in the development of therapeutic products for the treatment of rare and orphan diseases. Its product pipeline includes QRX003, QRX004, QRX007, and QRX008. The company was founded by Michael Myers and Denise Carter on March 5, 2018 and is headquartered in Ashburn, VA.

Quoin Pharmaceuticals Ltd - ADR

Quoin Pharmaceuticals is trending following news of positive clinical data for their QRX003 treatment, specifically in a pediatric peeling skin syndrome study. The community is actively discussing the stock's low float and potential for a short squeeze, drawing comparisons to other recent low-float biotech runners. Some traders caution about dilution and the company's history, while others remain bullish, citing the potential of the treatment and market opportunity.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending due to discussions around a potential short squeeze, fueled by its high short interest and Google's stake in the company, as well as its shift towards AI data centers. Community members are closely watching resistance levels and anticipating a breakout, comparing it to other stocks in the sector and discussing potential price targets. The stock's technical ratings and the broader context of data center shortages are also contributing to the increased interest.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASPI is trending due to high volume and speculation about a potential news leak, with community members discussing a possible short squeeze and potential catalysts. Bullish sentiment is fueled by upcoming milestones like the QLE spinoff, while others express skepticism and caution about the stock's volatility. Traders are actively monitoring price action and technical indicators, awaiting further company updates.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company ($ABAT) is trending as the stock price increases, spurring excitement among long-term investors who have been holding shares for several years and are now seeing significant gains. Community members are actively discussing potential price targets and the impact of upcoming news, particularly around the PFS (Pre-Feasibility Study). The company's positioning in lithium recycling, especially with potential government support and China's export controls, is also a key talking point.

Safe & Green Holdings Corp. is a design and construction services company, which engages in the provision of code engineered cargo shipping containers. It operates through the following segments: Construction, Medical, Development, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Medical segment consists of joint venture COVID-19 laboratory operations. The Development segment focuses on real property development. The Corporate and Support segment includes general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments. The company was founded on December 29, 1993 and is headquartered in Miami, FL.

Safe & Green Holdings Corp

SG Blocks Inc

SGBX is experiencing high volatility, driven by premarket gains and discussions around Q3 results or the OneQode pilot. The community is actively trading the stock, with some anticipating a short squeeze due to its micro float, while others express concerns about potential pump and dump schemes or dilution. Overall, the stock's price movement and potential for significant gains or losses are fueling the current interest.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

Churchill Capital Corp X ($CCCX) is trending as traders discuss its potential in the quantum computing sector, particularly compared to peers like $IONQ and $RGTI. The community highlights Infleqtion's existing contracts, partnership with NVIDIA, and a potential for significant upside, while some anticipate a near-term run to $30+ and compare it to previous high-flying SPACs. Chatter also mentions upcoming events and presentations, further fueling interest.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as investors react to recent news, including a new multi-launch agreement with Japan's iQPS. The community is actively discussing the potential impact of this deal, along with speculation about upcoming catalysts like the Neutron launch and potential government contracts. Some traders caution about short-term overvaluation, while long-term bulls remain confident in the company's growth prospects.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

MARA is trending as discussions revolve around its potential to catch up with other miners like CLSK and IREN, with some expressing frustration over its underperformance and management. Community members are debating whether its current valuation reflects its Bitcoin holdings and future AI prospects. Short interest remains high, fueling speculation about a potential squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Barclays⬆️the PT on $CYTK to $82 from $71 and reiterated at an Overweight rating. 
$BMY $EWTX 
Barclays said in its note: Ahead of aficamten Ph3 ACACIA data (1H26, likely March/April) in non-obstructive hypertrophic cardiomyopathy (nHCM), we spoke with 2 KOLs and conducted a deep dive on historical clinical data and statistical analysis. 
 
We see a high prob for a positive outcome for dual primary endpoints KCCQ-CSS (&gt;75%) and pVO2 (&gt;55%). 
 
We expect aficamten to become the first approved drug in nHCM and continue to see a high probability of on time (PDUFA Dec 26) approval in oHCM with a differentiated label. 
 
Based on our KOL feedback, we believe aficamten with superior safety profile (therefore operational ease of use) would become the preferred therapy in oHCM/nHCM. Reiterate OW and increase our PT to $82.

Stifel trimmed the PT on $CYTK to $95 from $96 and maintained at a Buy rating to Reflect the Company&#39;s Recently Upsized Convertible Notes Offering. 
$BMY $EWTX 
This is what Stifel had to say in its note to investors: 
Following the recent late-cycle meeting, CYTK continues to expect a differentiated REMS/label where, along with recent strong MAPLE data, management expects aficamten to 
(1) expand the CMI prescriber base; and 
(2) obtain preferential share vs. Camzyos -- potentially even within the first year. 
 
Meanwhile, in-light of ODYSSEY (almost working, despite dosing challenges) management&#39;s confident in ACACIA-HCM, highlighting recent FOREST data (consistent efficacy; patients dosed to -- and safely maintained at -- aficamten&#39;s highest doses) and their expertise in executing HCM trials. 
 
We are also updating our model to reflect their recent convert deal -- that, along with routine model maintenance, brings our TP to $95 (vs. $96).

StockTwits Web

Cytokinetics Inc

Bristol-Myers Squibb Co.

Edgewise Therapeutics Inc

Quantumup

 to $82 from $71 and reiterated at an Overweight rating. 


 
Barclays said in its note: Ahead of aficamten Ph3 ACACIA data (1H26, likely March/April) in non-obstructive hypertrophic cardiomyopathy (nHCM), we spoke with 2 KOLs and conducted a deep dive on historical clinical data and statistical analysis. 
 
We see a high prob for a positive outcome for dual primary endpoints KCCQ-CSS (>75%) and pVO2 (>55%). 
 
We expect aficamten to become the first approved drug in nHCM and continue to see a high probability of on time (PDUFA Dec 26) approval in oHCM with a differentiated label. 
 
Based on our KOL feedback, we believe aficamten with superior safety profile (therefore operational ease of use) would become the preferred therapy in oHCM/nHCM. Reiterate OW and increase our PT to $82.